1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C1944688054D629985257AB0007B08E3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/webcast-leverage-hol-functions-to-compete-healthcare-market?opendocument
18
19opendocument
2054.157.61.68
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services »

Research Webcast Series: Health Outcomes Liaisons: The New Information Conduits for Showing Value to Payers

ID: WEB-36


Pages: 1


Published: Pre-2014


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Overview



"Health Outcomes Liaisons: The New Information Conduits for Showing Value to Payers" pulls together quantitative and qualitative insights from a recent primary research study to highlight critical benchmarks and exclusive insights detailing how leading pharmaceutical, biotechnology, and medical device companies are leveraging their fledgling HOL functions to compete successfully in today’s outcomes-focused healthcare market.



Length: 45 minutes


Expect to learn:

  • Staffing and budget metrics for Health Outcomes Liaison programs
  • Scope, frequency, and timing of value-added services provided by HOLs
  • Methods for HOLs to engage with key internal and external customers, while differentiating themselves from Medical Science Liaisons
  • How to differentiate the roles of other educator groups, such as Medical Science Liaisons
  • Common pitfalls and next steps for leaders of HOLs

Invited attendees: Executives and managers who lead or oversee Health Outcomes Liaisons, Managed Markets, Payer Strategy, or Health Economics and Outcomes Research are invited to attend. Your colleagues in Medical Affairs, Account Management, and Sales may also benefit from attending.


Speakers: Cameron Tew and Vahid Sanii


Cameron Tew
Executive Director of Research

Cameron Tew joined Best Practices, LLC, in early 2004, bringing a wealth of experience in research, analysis, field interviews and management/project leadership from 14 years in the media industry. Cameron works directly with clients on existing initiatives and also contributes to the development of new services to help biopharmaceutical and medical device companies improve their commercial operations.

Cameron has delivered industry presentations on a breadth of topics including new product planning, product launch, competitive intelligence, Medical Affairs, Medical Science Liaisons, sales communication and talent management. He has been published and quoted in various industry and technology publications including Med Ad News, Pharma Voice, Pharma Focus, First Word Reports, Product Management Today, Pharmaceutical Technology and Innovations in Pharma Technology.

Vahid Sanii
Head of Analytics

Vahid supports clients in the Pharmaceutical, Biotechnology, Health Services and Medical Device sectors. He has served on projects that have provided several top pharmaceutical companies with critical insights into the changing landscape of Medical Affairs, New Product Launch, and the evolving role of Medical Science Liaisons. He recently worked on a study that detailed winning strategic approaches for engaging emerging regions in clinical affairs activities. Prior to joining Best Practices, Vahid gained extensive analytical experience in the academia field that included primary research in neurobiology, economics and finance. Vahid graduated from the University of North Carolina at Chapel Hill with a bachelor’s degree in Economics.


System Requirements:
PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server
Macintosh®-based attendees
Required: Mac OS® X 10.6 or newer
Mobile attendees
Required: iPhone®, iPad®, Android™ phone or Android tablet

Industries Profiled:
Biotech; Medical Device; Pharmaceutical


Companies Profiled:
Pharmaceutical Companies